BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34999039)

  • 21. Preparation, Optimization, and Evaluation of Methoxy Poly(ethylene glycol)-
    Mohamadpour H; Azadi A; Rostamizadeh K; Andalib S; Saghatchi Zanjani MR; Hamidi M
    ACS Chem Neurosci; 2020 Mar; 11(5):783-795. PubMed ID: 32043866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
    Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
    Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming multidrug resistance of breast cancer cells by the micellar doxorubicin nanoparticles of mPEG-PCL-graft-cellulose.
    Chen CH; Cuong NV; Chen YT; So RC; Liau I; Hsieh MF
    J Nanosci Nanotechnol; 2011 Jan; 11(1):53-60. PubMed ID: 21446406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes.
    Hattori Y; Saito H; Oku T; Ozaki KI
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Small interfering RNA delivery mediated by mPEG-PCL-g-PEI polymer nanoparticles].
    Huang W; Lü M; Gao ZG; Jin MJ; Yang CQ
    Yao Xue Xue Bao; 2011 Mar; 46(3):344-9. PubMed ID: 21626792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
    Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
    Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles.
    Kheiri Manjili H; Ghasemi P; Malvandi H; Mousavi MS; Attari E; Danafar H
    Eur J Pharm Biopharm; 2017 Jul; 116():17-30. PubMed ID: 27756682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of Bcl-2 conversion gene by MPEG-PCL-PEI-FA cationic copolymer to combat therapeutic resistant cancer.
    Li Z; Liu X; Chen X; Chua MX; Wu YL
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():66-72. PubMed ID: 28482577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic activity of poly-ɛ-caprolactone lipid-core nanocapsules loaded with lycopene-rich extract from red guava (Psidium guajava L.) on breast cancer cells.
    Vasconcelos AG; Valim MO; Amorim AGN; do Amaral CP; de Almeida MP; Borges TKS; Socodato R; Portugal CC; Brand GD; Mattos JSC; Relvas J; Plácido A; Eaton P; Ramos DAR; Kückelhaus SAS; Leite JRSA
    Food Res Int; 2020 Oct; 136():109548. PubMed ID: 32846600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids.
    Oner E; Kotmakci M; Baird AM; Gray SG; Debelec Butuner B; Bozkurt E; Kantarci AG; Finn SP
    J Nanobiotechnology; 2021 Mar; 19(1):71. PubMed ID: 33685469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.
    Chakravarti B; Siddiqui JA; Dwivedi SK; Deshpande S; Samanta K; Bhatta RS; Panda G; Prabhakar YS; Konwar R; Sanyal S; Chattopadhyay N
    Mol Cell Endocrinol; 2011 May; 338(1-2):68-78. PubMed ID: 21457754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-delivery of hydrophilic and hydrophobic drugs by micelles: a new approach using drug conjugated PEG-PCLNanoparticles.
    Danafar H; Rostamizadeh K; Davaran S; Hamidi M
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1908-1918. PubMed ID: 28737462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.
    Yu H; Tang Z; Li M; Song W; Zhang D; Zhang Y; Yang Y; Sun H; Deng M; Chen X
    J Biomed Nanotechnol; 2016 Jan; 12(1):69-78. PubMed ID: 27301173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.
    Zhou H; Lv S; Zhang D; Deng M; Zhang X; Tang Z; Chen X
    Acta Biomater; 2018 Jun; 73():388-399. PubMed ID: 29694920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer.
    Wang Y; Liu P; Du J; Sun Y; Li F; Duan Y
    J Biomater Sci Polym Ed; 2013; 24(10):1219-32. PubMed ID: 23713424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.